Interestingly, gains and amplifications of FOXO1 are evident in colorectal cancers (Aaltonen et al, 2020), and levels of FOXO1 show a moderate increase with advanced tumour stages of colorectal cancer (Appendix Fig. S7). The gene discussed is FOXO1; the disease is neoplasm.